113 related articles for article (PubMed ID: 12832218)
1. Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11.
Wang X; Wang Z; Christensen ND; Dillner J
Virology; 2003 Jun; 311(1):213-21. PubMed ID: 12832218
[TBL] [Abstract][Full Text] [Related]
2. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.
Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD
Virol J; 2012 Feb; 9():52. PubMed ID: 22356831
[TBL] [Abstract][Full Text] [Related]
3. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.
Guan J; Bywaters SM; Brendle SA; Lee H; Ashley RE; Christensen ND; Hafenstein S
J Virol; 2015 Dec; 89(23):12108-17. PubMed ID: 26401038
[TBL] [Abstract][Full Text] [Related]
4. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.
Orozco JJ; Carter JJ; Koutsky LA; Galloway DA
J Virol; 2005 Aug; 79(15):9503-14. PubMed ID: 16014913
[TBL] [Abstract][Full Text] [Related]
6. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
7. A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.
Lee H; Brendle SA; Bywaters SM; Guan J; Ashley RE; Yoder JD; Makhov AM; Conway JF; Christensen ND; Hafenstein S
J Virol; 2015 Jan; 89(2):1428-38. PubMed ID: 25392224
[TBL] [Abstract][Full Text] [Related]
8. A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.
Xia L; Xian Y; Wang D; Chen Y; Huang X; Bi X; Yu H; Fu Z; Liu X; Li S; An Z; Luo W; Zhao Q; Xia N
Sci Rep; 2016 Jan; 6():19042. PubMed ID: 26750243
[TBL] [Abstract][Full Text] [Related]
9. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.
Kirnbauer R; Hubbert NL; Wheeler CM; Becker TM; Lowy DR; Schiller JT
J Natl Cancer Inst; 1994 Apr; 86(7):494-9. PubMed ID: 8133532
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1.
Carter JJ; Wipf GC; Benki SF; Christensen ND; Galloway DA
J Virol; 2003 Nov; 77(21):11625-32. PubMed ID: 14557648
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera.
Wang Z; Christensen N; Schiller JT; Dillner J
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2209-15. PubMed ID: 9292008
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1.
White WI; Wilson SD; Palmer-Hill FJ; Woods RM; Ghim SJ; Hewitt LA; Goldman DM; Burke SJ; Jenson AB; Koenig S; Suzich JA
J Virol; 1999 Jun; 73(6):4882-9. PubMed ID: 10233949
[TBL] [Abstract][Full Text] [Related]
14. Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.
Ryding J; Dahlberg L; Wallen-Öhman M; Dillner J
J Gen Virol; 2007 Mar; 88(Pt 3):792-802. PubMed ID: 17325351
[TBL] [Abstract][Full Text] [Related]
15. Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6.
Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 1999 Jul; 73(7):6188-90. PubMed ID: 10364381
[TBL] [Abstract][Full Text] [Related]
16. Development of a non-denaturing electrophoresis system for characterization of neutralizing epitopes on HPV virus-like particles.
Studentsov YY; Burk RD
J Virol Methods; 2007 Feb; 139(2):208-19. PubMed ID: 17137641
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.
Roden RB; Armstrong A; Haderer P; Christensen ND; Hubbert NL; Lowy DR; Schiller JT; Kirnbauer R
J Virol; 1997 Aug; 71(8):6247-52. PubMed ID: 9223527
[TBL] [Abstract][Full Text] [Related]
18. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.
Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P
J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978
[TBL] [Abstract][Full Text] [Related]
19. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
[TBL] [Abstract][Full Text] [Related]
20. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
